761 related articles for article (PubMed ID: 16390397)
1. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.
Vikrant S; Agarwal SK; Gupta S; Bhowmik D; Tiwari SC; Dash SC; Guleria S; Mehta SN
Transpl Infect Dis; 2005; 7(3-4):99-108. PubMed ID: 16390397
[TBL] [Abstract][Full Text] [Related]
2. Use of isoniazid chemoprophylaxis in renal transplant recipients.
Naqvi R; Naqvi A; Akhtar S; Ahmed E; Noor H; Saeed T; Akhtar F; Rizvi A
Nephrol Dial Transplant; 2010 Feb; 25(2):634-7. PubMed ID: 19783599
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of isoniazid prophylaxis in renal allograft recipients.
Naqvi R; Akhtar S; Noor H; Saeed T; Bhatti S; Sheikh R; Ahmed E; Akhtar F; Naqvi A; Rizvi A
Transplant Proc; 2006 Sep; 38(7):2057-8. PubMed ID: 16979998
[TBL] [Abstract][Full Text] [Related]
4. Isoniazid hepatotoxicity in renal transplant recipients.
Antony SJ; Ynares C; Dummer JS
Clin Transplant; 1997 Feb; 11(1):34-7. PubMed ID: 9067692
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence.
Falagas ME; Voidonikola PT; Angelousi AG
Int J Antimicrob Agents; 2007 Dec; 30(6):477-86. PubMed ID: 17913470
[TBL] [Abstract][Full Text] [Related]
6. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient.
Agarwal SK; Gupta S; Dash SC; Bhowmik D; Tiwari SC
Int Urol Nephrol; 2004; 36(3):425-31. PubMed ID: 15783119
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis in renal transplant recipients: the evidence for prophylaxis.
Currie AC; Knight SR; Morris PJ
Transplantation; 2010 Oct; 90(7):695-704. PubMed ID: 20647975
[TBL] [Abstract][Full Text] [Related]
9. Reduction of clinical tuberculosis in HIV-infected males with isoniazid prophylaxis.
Alaei K; Alaei A; Mansouri D
East Mediterr Health J; 2002 Nov; 8(6):754-7. PubMed ID: 15568452
[TBL] [Abstract][Full Text] [Related]
10. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
[TBL] [Abstract][Full Text] [Related]
11. Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease.
Mohammed A; Myer L; Ehrlich R; Wood R; Cilliers F; Maartens G
Int J Tuberc Lung Dis; 2007 Oct; 11(10):1114-20. PubMed ID: 17945069
[TBL] [Abstract][Full Text] [Related]
12. TB prevention in HIV clinics in New York City.
Sackoff JE; Torian LV; Frieden TR
Int J Tuberc Lung Dis; 2001 Feb; 5(2):123-8. PubMed ID: 11258505
[TBL] [Abstract][Full Text] [Related]
13. Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis.
Fitzgerald DW; Morse MM; Pape JW; Johnson WD
Clin Infect Dis; 2000 Dec; 31(6):1495-7. PubMed ID: 11096020
[TBL] [Abstract][Full Text] [Related]
14. [Isoniazid prophylaxis for pulmonary tuberculosis in Chinese patients with rheumatoid arthritis receiving long-term methotrexate therapy].
Xie QB; Wen FQ; Yin G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):138-40. PubMed ID: 19292064
[TBL] [Abstract][Full Text] [Related]
15. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases.
Sneag DB; Schaaf HS; Cotton MF; Zar HJ
Pediatr Infect Dis J; 2007 Dec; 26(12):1142-6. PubMed ID: 18043453
[TBL] [Abstract][Full Text] [Related]
16. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC
Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.
Mok MY; Lo Y; Chan TM; Wong WS; Lau CS
J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterium tuberculosis infection in renal transplant recipients.
Ergun I; Ekmekci Y; Sengul S; Kutlay S; Dede F; Canbakan B; Erbay B
Transplant Proc; 2006 Jun; 38(5):1344-5. PubMed ID: 16797298
[TBL] [Abstract][Full Text] [Related]
19. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.
Tsakiris DJ; Stel VS; Finne P; Fraser E; Heaf J; de Meester J; Schmaldienst S; Dekker F; Verrina E; Jager KJ
Nephrol Dial Transplant; 2010 Apr; 25(4):1200-6. PubMed ID: 20037169
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
Sterling TR; Brehm WT; Moore RD; Chaisson RE
Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
